Parallax Volatility Advisers’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-10,100
| Closed | -$3.93M | – | 1661 |
|
|
2025
Q2 | $3.93M | Buy |
10,100
+8,300
| +461% | +$3.34M | 0.01% | 683 |
|
|
2025
Q1 | $783K | Sell |
1,800
-600
| -25% | -$241K | ﹤0.01% | 1113 |
|
|
2024
Q4 | $885K | Sell |
2,400
-1,100
| -31% | -$460K | ﹤0.01% | 1357 |
|
|
2024
Q3 | $1.82M | Buy |
3,500
+400
| +13% | +$214K | ﹤0.01% | 1160 |
|
|
2024
Q2 | $1.68M | Buy |
3,100
+800
| +35% | +$423K | ﹤0.01% | 1099 |
|
|
2024
Q1 | $1.19M | Sell |
2,300
-200
| -8% | -$99.5K | ﹤0.01% | 1186 |
|
|
2023
Q4 | $1.18M | Hold |
2,500
| – | – | ﹤0.01% | 1352 |
|
|
2023
Q3 | $1.09M | Buy |
2,500
+2,300
| +1,150% | +$1.04M | ﹤0.01% | 1331 |
|
|
2023
Q2 | $88.9K | Sell |
200
-600
| -75% | -$277K | ﹤0.01% | 2011 |
|
|
2023
Q1 | $368K | Sell |
800
-200
| -20% | -$95.2K | ﹤0.01% | 1824 |
|
|
2022
Q4 | $513K | Sell |
1,000
-800
| -44% | -$406K | ﹤0.01% | 1874 |
|
|
2022
Q3 | $818K | Sell |
1,800
-4,600
| -72% | -$2.2M | ﹤0.01% | 1802 |
|
|
2022
Q2 | $3.09M | Buy |
+6,400
| New | +$3.17M | ﹤0.01% | 1170 |
|
|
2020
Q4 | – | Sell |
-214,300
| Closed | -$57.6M | – | 2867 |
|
|
2020
Q3 | $57.6M | Buy |
214,300
+66,200
| +45% | +$17.8M | 0.04% | 362 |
|
|
2020
Q2 | $39M | Buy |
148,100
+26,600
| +22% | +$7.1M | 0.05% | 324 |
|
|
2020
Q1 | $27.6M | Buy |
121,500
+80,200
| +194% | +$21.9M | 0.04% | 327 |
|
|
2019
Q4 | $12.5M | Sell |
41,300
-5,700
| -12% | -$1.57M | 0.01% | 579 |
|
|
2019
Q3 | $11.3M | Buy |
47,000
+2,500
| +6% | +$685K | 0.01% | 554 |
|
|
2019
Q2 | $12.6M | Buy |
44,500
+32,000
| +256% | +$8.74M | 0.01% | 464 |
|
|
2019
Q1 | $3.59M | Sell |
12,500
-164,500
| -93% | -$47.6M | ﹤0.01% | 784 |
|
|
2018
Q4 | $46.5M | Buy |
177,000
+84,600
| +92% | +$23.3M | 0.06% | 203 |
|
|
2018
Q3 | $25.3M | Sell |
92,400
-58,600
| -39% | -$15.2M | 0.03% | 235 |
|
|
2018
Q2 | $35.9M | Buy |
+151,000
| New | +$35M | 0.05% | 165 |
|
|
2016
Q1 | – | Sell |
-1,000
| Closed | -$140K | – | 2751 |
|
|
2015
Q4 | $140K | Buy |
+1,000
| New | +$138K | ﹤0.01% | 2011 |
|
|
2015
Q3 | – | Sell |
-200
| Closed | -$33K | – | 3134 |
|
|
2015
Q2 | $33K | Sell |
200
-6,200
| -97% | -$991K | ﹤0.01% | 2711 |
|
|
2015
Q1 | $988K | Sell |
6,400
-37,800
| -86% | -$5.38M | ﹤0.01% | 1269 |
|
|
2014
Q4 | $5.55M | Sell |
44,200
-124,900
| -74% | -$15.4M | 0.02% | 656 |
|
|
2014
Q3 | $20.2M | Buy |
169,100
+141,200
| +506% | +$16.2M | 0.06% | 257 |
|
|
2014
Q2 | $3M | Buy |
27,900
+24,400
| +697% | +$2.51M | 0.01% | 629 |
|
|
2014
Q1 | $349K | Buy |
3,500
+600
| +21% | +$54.3K | ﹤0.01% | 1176 |
|
|
2013
Q4 | $268K | Sell |
2,900
-5,700
| -66% | -$506K | ﹤0.01% | 1315 |
|
|
2013
Q3 | $717K | Buy |
8,600
+6,300
| +274% | +$540K | ﹤0.01% | 747 |
|
|
2013
Q2 | $187K | Buy |
+2,300
| New | +$172K | ﹤0.01% | 1050 |
|
Other funds holding ELV
VCM
VPM
Parallax Volatility Advisers's ELV Position: Q1 2026 in Review
Parallax Volatility Advisers sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 1,576 shares — an estimated $552K sold.
Parallax Volatility Advisers first reported a position in ELV in Q2 2013 and held it in 29 quarters. The position peaked at $15.3M in Q3 2020. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Parallax Volatility Advisers reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
- Parallax Volatility Advisers sold 1,576 Elevance Health shares in Q1 2026, an estimated $552K.
- Parallax Volatility Advisers first reported a position in Elevance Health in Q2 2013 and held it in 29 quarters.
- Parallax Volatility Advisers's Elevance Health position peaked at $15.3M in Q3 2020.
- 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.